From November 1 to 3, CPHI Worldwide Europe was held successfully in Frankfurt, Germany. As one of the world's largest professional pharmaceutical industry exhibition, CPHI Worldwide Europe fully demonstrated the entire pharmaceutical supply chain from active pharmaceutical ingredients (API), pharmaceutical packaging equipment (P-MEC) to finished dosage form (FDF), which welcomed and was widely recognized by global players in pharmaceutical raw material industry.

CPHI Worldwide Europe attracted more than 2,500 exhibitors and more than 45,000 professional merchants from all over the world. The exhibits involved pharmaceutical excipients, pharmaceutical raw materials, preparations, veterinary drugs, feed, intermediates and more.As a globally gathered exhibition, CPHI Worldwide Europe has also become an ideal platform to keep abreast of the latest industry information and market development in the pharmaceutical industry.

With the rapid development of the global pharmaceutical market, Laviana Pharma continues to invest in the enhancement of R&D and production capacity, accelerating the construction of the GMP production base in Cangzhou and launching the production base project in Anhui to further improve the comprehensive service capacity. Due to its investment in R&D and production, Laviana Pharma maintains its growth and vitality in the competitive environment, and has developed into a player widely known and praised by industry insiders.